[1] |
Grinstein J, Cannon CP. Aspirin resistance: current status and role of tailored therapy[J].Clin Cardiol,2012,35(11):673-681.
|
[2] |
Pappas JM,Westengard JC,Bull BS.Population variability in the effect of aspirin on platelet function.Implications for clinical trials and therapy[J].Arch Pathol Lab Med,1994,118(8):801-804.
|
[3] |
Grotemeyer KH.Effects of acetylsalicylic acid in stroke patients.Evidence of nonresponders in a subpopulation of treated patients[J].Thromb Res,1991,63(6):587-593.
|
[4] |
Dharmasaroja PA,Muengtaweepongsa S,Sae-Lim S.Aspirin nonresponders in patients with ischaemic stroke[J].Blood Coagul Fibrinolysis,2013,24(4):361-364.
|
[5] |
Blann AD,Kuzniatsova N,Lip GY.Vascular and platelet responses to aspirin in patients with coronary artery disease[J].Eur J Clin Invest,2013,43(1):91-99.
|
[6] |
Würtz M,Nissen PH,Grove EL,et al.Genetic determinants of on-aspirin platelet reactivity:focus on the influence of PEAR1[J].PLoS ONE,2014,9(10):e111816.
|
[7] |
Floyd CN,Ferro A.The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs:a systematic review and meta-analysis[J].Br J Clin Pharmacol,2014,77(3):446-457.
|
[8] |
Floyd CN,Mustafa A,Ferro A.The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for myocardial infarction:a meta-analysis[J].PLoS ONE,2014,9(7):e101518.
|
[9] |
Verdoia M,Cassetti E,Schaffer A,et al.Platelet glycoprotein IIIa Leu33Pro gene polymorphism and coronary artery disease:a meta-analysis of cohort studies[J].Platelets,2015,26(6):530-535.
|
[10] |
Verdoia M,Cassetti E,Schaffer A,et al.Relationship between glycoprotein IIIa platelet receptor gene polymorphism and coronary artery disease[J].Angiology,2015,66(1):79-85.
|
[11] |
Michelson AD,Furman MI,Goldschmidt-Clermont P,et al.Platelet GP IIIa Pl(A)polymorphisms display different sensitivities to agonists[J].Circulation,2000,101(9):1013-1018.
|
[12] |
Lewis JP,Ryan K,O′Connell JR,et al.Genetic variation in PEAR1 is associated with platelet aggregation and cardiovascular outcomes[J].Circ Cardiovasc Gene,2013,6(2):184-192.
|
[13] |
Sánchez-Borges M,Acevedo N,Vergara C,et al.The A-444C polymorphism in the leukotriene C4 synthase gene is associated with aspirin-induced urticaria[J].J Investig Allergol Clin Immunol,2009,19(5):375-382.
|
[14] |
Kim SH, Ye YM, Lee SK, et al. Genetic mechanism of aspirin-induced urticaria/angioedema[J].Curr Opin Allergy Clin Immunol,2006,6(4):266-270.
|
[15] |
Park SM,Park JS,Park HS,et al.Unraveling the genetic basis of aspirin hypersensitivity in asthma beyond arachidonate pathways[J].Allergy Asthma Immunol Res,2013,5(5):258-276.
|
[16] |
Jakubowska A,Rozkrut D,Antoniou A,et al.The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks:results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers[J].Breast Cancer Res Treat,2009,121(3):639-649.
|
[17] |
Pan W,Byrne-Steele M,Wang C,et al.DNA polymerase preference determines PCR priming efficiency[J].BMC Biotechnol,2014,14:10.
|
[18] |
Li XX,Zhao HY,Yang YT,et al.Comparing the three methods to extract human genomic DNA from whole blood[J].Prog Mod Biomed(现代生物医学进展),2013,13(27):5221-5225.
|
[19] |
Chu YN,Zhang JY,Feng LY,et al.Establishment of a rapid and inexpensive identification method for HLA-B*58:01 genotype[J].Chin J Anal Chem(分析化学),2016,44(5):693-697.
|
[20] |
Zhou G,Song Q.Advances and Clinical Practice in Pyrosequencing[M].New York:Springer,2016:14.
|